These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 8993332)

  • 1. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide.
    Krishnaswamy S; Vlasuk GP; Bergum PW
    Biochemistry; 1994 Jun; 33(25):7897-907. PubMed ID: 8011652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosites determine macromolecular substrate recognition by prothrombinase.
    Krishnaswamy S; Betz A
    Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
    Rezaie AR
    Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
    Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
    Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles.
    Krishnaswamy S; Jones KC; Mann KG
    J Biol Chem; 1988 Mar; 263(8):3823-34. PubMed ID: 3346225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.
    Buddai SK; Toulokhonova L; Bergum PW; Vlasuk GP; Krishnaswamy S
    J Biol Chem; 2002 Jul; 277(29):26689-98. PubMed ID: 12011050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of factor Va on the active site of factor Xa.
    Walker RK; Krishnaswamy S
    J Biol Chem; 1993 Jul; 268(19):13920-9. PubMed ID: 8314758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
    Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
    Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosite binding tethers the macromolecular substrate to the prothrombinase complex and directs cleavage at two spatially distinct sites.
    Boskovic DS; Krishnaswamy S
    J Biol Chem; 2000 Dec; 275(49):38561-70. PubMed ID: 10984491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation.
    Krishnaswamy S
    J Biol Chem; 1990 Mar; 265(7):3708-18. PubMed ID: 2303476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.